Advertisement
Advertisement
ETON
Eton Pharmaceutcials, Inc. Common Stock
29.96
USDSponsored
-0.86
-2.79%
May 14, 16:00 UTC -4
Closed
After-Market
30.05
+0.09
+0.30%
ETON Earnings Reports
Positive Surprise Ratio
ETON beat 12 of 28 last estimates.
43%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$26.20M
/$0.14
Implied change from Q1 26 (Revenue/ EPS)
+7.94%
/+180.00%
Implied change from Q2 25 (Revenue/ EPS)
+38.40%
/-240.00%
Eton Pharmaceutcials, Inc. Common Stock earnings per share and revenue
On May 14, 2026, ETON reported earnings of 0.05 USD per share (EPS) for Q1 26, missing the estimate of 0.09 USD, resulting in a -45.53% surprise. Revenue reached 24.27 million, compared to an expected 22.76 million, with a 6.64% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.14 USD, with revenue projected to reach 26.20 million USD, implying an increase of 180.00% EPS, and increase of 7.94% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CorMedix Inc.
Report Date
May 14, 2026 For Q1 26
Estimate
$0.37
Actual
$0.43
Surprise
+15.59%
REGENXBIO Inc.
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.36
Actual
-$1.72
Surprise
-25.94%
Autolus Therapeutics plc - ADR
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.27
Surprise
-2.94%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+217.65%
Alpha Cognition Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.39
Actual
-$0.37
Surprise
+6.19%
Elutia Inc. Class A Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
RenovoRx, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Hyperion DeFi, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.74
Actual
-$0.82
Surprise
-210.13%
Dare Bioscience, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.20
Surprise
+32.39%
Biofrontera Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.41
Surprise
-249.53%
FAQ
What were Eton Pharmaceutcials, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Eton Pharmaceutcials, Inc. Common Stock reported EPS of $0.05, missing estimates by -45.53%, and revenue of $24.27M, 6.64% above expectations.
How did the market react to Eton Pharmaceutcials, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Eton Pharmaceutcials, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Eton Pharmaceutcials, Inc. Common Stock's next earnings report?
Based on --
analysts, Eton Pharmaceutcials, Inc. Common Stock is expected to report EPS of $0.14 and revenue of $26.20M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement